Dr. Guy Hatchard recently encountered numerous friends grappling with persistent health issues, painting a stark picture of New Zealand’s overwhelmed healthcare system, reflective of trends in highly vaccinated nations.
Dr. Hatchard contends that merely pouring funds into the system won’t suffice until a candid discussion about the underlying causes is initiated.
He delves into the factors contributing to the surge in health problems, notably the concerning rise in cancers among young individuals. This comprehensive piece sheds light on crucial information often overlooked by official channels.
As hospitals grapple with an unprecedented influx of patients, questions about the safety of COVID-19 vaccines persist.
Dr. Harvey Risch, a distinguished expert in cancer and chronic diseases from Yale School of Public Health, highlights an alarming trend—vaccinated young people developing cancers at previously unthinkable rates. This phenomenon is attributed to the vaccine’s impact on the immune system’s ability to combat abnormal cancer cells.
Surprisingly, these critical reports are conspicuously absent from mainstream media and political discourse, with the prevailing narrative continuing to promote further vaccinations.
Dr. Paul Offit, a leading advocate for immunization and a member of the US FDA’s advisory committee, has voiced his reservations about the mRNA COVID booster, signaling potential longer-lasting effects on vaccine-induced myocardial health. This revelation raises pertinent questions about the trustworthiness of medical advice, particularly when it comes to personal vaccination choices.
Research underscores the lingering presence of COVID viral RNA and its impact on immune activation, further underscoring the need for a thorough examination of long-term effects. It is essential to differentiate between COVID-19 and vaccination-induced effects, acknowledging the complex interplay between the two.
Dr. Hatchard urges a reconsideration of the origins of COVID-19 and the subsequent vaccination drive. He underscores the potential implications of biotechnology research and calls for a more robust and research-backed approach to health guidance.
Advocating for open dialogue and action, he emphasizes the power of collective voices in steering the narrative and influencing policy decisions. The UK’s recent policy backtrack on mandating health sector employees serves as a testament to the potential impact of public outcry.
In a landscape filled with uncertainties surrounding biotechnology advancements, it is imperative to advocate for research-backed information, individual choice, and transparent governance.
Dr. Hatchard urges individuals to take charge of their health by seeking avenues for reporting adverse reactions and seeking legal counsel if needed.